Mamiko Sakata-Yanagimoto1, Yusuke Kiyoki1, Nguyen Tran1, Manabu Fujisawa1, Yasuhito Nanya2, Kantaro Ishitsuka1, Haruka Momose1, Atsushi Shinagawa3, Takuya Suyama3, Yuji Sato4, Hidekazu Nishikii1, Naoshi Obara1, Manabu Kusakabe1, Takayasu Kato1, Yasuhisa Yokoyama1, Naoki Kurita1, Yuichi Hasegawa1, Seishi Ogawa2, Shigeru Chiba1 (1.Hematol., Tsukuba Univ., Ibaraki, Japan, 2.Pathol. and Tumor Biol., Kyoto Univ., Kyoto, Japan, 3.Hematol., Hitachi General Hosp., 4.Hematol., Tsukuba Memorial Hosp.)
Session information
Oral Session
Oral Session 1-10D PTCL: Pathophysiology/Prognosis
Fri. Oct 11, 2019 4:30 PM - 5:30 PM No.10 (Tokyo International Forum, 4F G409)
Chair: Takero Shindo (Kyoto University Graduate School of Medicine Hematology Oncology)
Joji Shimono1, Takashi Ishio1, Hideki Goto1, Hajime Kobayashi2, Akio Shigematsu3, Shuichi Ota3, Yutaka Tsutsumi4, Yasutaka Kakinoki5, Satoshi Yamamoto6, Mitsutoshi Kurosawa7, Takeshi Kondo8, Hajime Sakai9, Takuto Miyagishima10, Hiroshi Iwasaki11, Yoshihito Haseyama12, Yasuyuki Kunieda13, Takahiro Nagashima14, Mitsufumi Nishio15, Satoshi Hashino16, Yutaka Hatanaka17, Yoshihiro Matsuno18, Masao Nakagawa1, Takanori Teshima1 (1.Hokkaido University, Hematology, Hokkaido, Sapporo, Japan, 2.Obihiro Kosei Hospital, Hematology, Obihiro, Japan, 3.Sapporo Hokuyu Hospital, Hematology, Sapporo, Japan, 4.Hakodate City Hospital, Hematology, Hakoddate, Japan, 5.Asahikawa City Hospital, Hematology, Asahikawa, Japan, 6.Sapporo City Hospital, Hematology, Sapporo, Japan, 7.Hokkaido Cancer Center, Hematology, Sapporo, Japan, 8.Aiiku Hospital, Hematology, Sapporo, Japan, 9.Teine keijinkai Hospital, Hematology, Sapporo, Japan, 10.Kushiro Rosai Hospital, Hematology, Kushiro, Japan, 11.Sapporo Kosei Hospital, Hematology, Japan, 12.Tonan Hospital, Hematology, Sapporo, Japan, 13.Wakkanai City Hospital, Internal Medicine, Wakkanai, Jaan, 14.Kitami Red Cross Hoapital, Hematology, Kitami, Japan, 15.NTT East Sapporo Hospital, Hematology, Sapporo, Japan, 16.Hokkaido University, Health Care Center, Sapporo, Japan, 17.Hokkaido University, Genome Companion Diagnostics, Sapporo, Japan, 18.Hokkaido Univeristy, Pathilogy, Sapporo, Japan)
Yuko Shirouchi, Masahiro Yokoyama, Takanori Fukuta, Norihito Inoue, Hideki Uryu, Yoshiharu Kusano, Noriko Nishimura, Yuko Mishima, Yasuhito Terui (Hematology-Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan)
Mayumi Hatsuse1, Daisuke Ide1, Yoko Taminishi1,2, Saori Matsui1, Shinichi Fuchida1, Akira Okano1,3, Satoshi Murakami1, Hirokazu Nakamine4, Chihiro Shimazaki1 (1.Hematol, Kyoto Kuramaguchi Medical center, Kyoto, Japan, 2.Hematol., Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Hematol., Omihachiman Community Medical Center, Shiga, Japan, 4.Laboratory Med, Baptist Hospltal, Kyoro, Japan)
Kenji Motohashi1, Rika Sakai1, Takayuki Sakuma1, Ayako Matsumura1, Hiroyuki Takahashi1, Ayumi Numata1, Hirotaka Takasaki1, Kiyoshi Ando2, Hideaki Nakajima3 (1.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 2.Department of Hematology and Oncology, Tokai University School of Medicine, 3.Hematology and Clinical Immunology, Yokohama City University School of Medicine)
Seiichiro Katagiri1, Daigo Akahane1, Tamiko Suguro1, Michiyo Asano1, Yuko Tanaka1, Nahoko Furuya1, Hiroaki Fujimoto1, Naoya Nakamura2, Kazuma Ohyashiki1 (1.Department of Hematology, Tokyo Medical University, 2.Department of Pathology, Tokai University School of Medicine)